EANM Translational Molecular Imaging & Therapy (TMI&T)

TMI&T Committee Mission Statement

Modern medicine is facing the challenge to apply minimally invasive treatment strategies that suit the needs of the individual patient. This concept, entitled precision medicine, aims to improve patient care by stratifying patients into sub-groups that can be managed with specific optimized treatment plans. Due to the unique possibility to characterize the molecular fingerprint of a disease via non-invasive imaging techniques, nuclear medicine plays an essential role in this stratification process. Not only can disease-specific imaging help to non-invasively define the molecular features of a disease, in doing so, it can make the field of nuclear medicine rise above and beyond its diagnostic role and allow image-guided therapy delivery. One can even argue that well established nuclear medicine topics such as “molecular imaging, isotope-based therapy, image-guided therapy, and theranostics” are instrumental for the realization of precision medicine within the European healthcare system.

The success of nuclear medicine within Europe is dependent on its three pillars:

1) clinical implementation of available nuclear medicine technologies,
2) development of innovative nuclear medicine technologies, and
3) translating new developments from preclinical environment into the clinic.

It is in the latter where the EANM Translational Molecular Imaging & Therapy (TMI&T) Committee can provide value, by connecting innovations with clinical need and vice versa.

The EANM TMI&T Committee is an expert multidisciplinary group responsible for scientific counselling and education provider on translation of basic research into clinical application in the field of Nuclear Medicine.

Committee aim: Educate nuclear medicine community on the do’s and don’ts of translational science and facilitate interaction between the clinical and technical, basic science oriented EANM committees. As interface towards external key-players, the TMI&T Committee facilitates coordination, organisation, professionalization between all involved parties, including sister-scientific societies, industry and national bodies.